Similar articles for PMID: 28798034

Year	Number of Results
1998	1
1999	1
2000	2
2001	2
2002	4
2003	3
2004	2
2005	1
2006	2
2007	7
2008	5
2009	1
2010	1
2011	3
2012	1
2013	2
2014	6
2015	6
2016	12
2017	18
2018	13
2019	9
2020	8
2021	9
2022	5
2023	1

1

¹⁸F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?

Barrington SF, Johnson PWM. Barrington SF, et al. J Nucl Med. 2017 Oct;58(10):1539-1544. doi: 10.2967/jnumed.116.181347. Epub 2017 Aug 10. J Nucl Med. 2017. PMID: 28798034 Free PMC article. Review.

2

¹⁸F-FDG PET/CT in the clinical management of patients with lymphoma.

Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D. Tamayo P, et al. Rev Esp Med Nucl Imagen Mol. 2017 Sep-Oct;36(5):312-321. doi: 10.1016/j.remn.2017.03.004. Epub 2017 May 5. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28483374 Review. English, Spanish.

3

PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

Phillips EH, Iype R, Wirth A. Phillips EH, et al. Br J Radiol. 2021 Nov 1;94(1127):20210576. doi: 10.1259/bjr.20210576. Epub 2021 Sep 14. Br J Radiol. 2021. PMID: 34520242 Free PMC article. Review.

4

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Barrington SF, Kluge R. Barrington SF, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28411336 Free PMC article. Review.

5

Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.

Juweid ME, Mueller M, Alhouri A, A-Risheq MZ, Mottaghy FM. Juweid ME, et al. Cancer. 2021 Oct 15;127(20):3727-3741. doi: 10.1002/cncr.33772. Epub 2021 Jul 19. Cancer. 2021. PMID: 34286864 Free article. Review.

6

FDG-PET/CT in the management of lymphomas: current status and future directions.

El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY. El-Galaly TC, et al. J Intern Med. 2018 Oct;284(4):358-376. doi: 10.1111/joim.12813. Epub 2018 Jul 24. J Intern Med. 2018. PMID: 29989234 Free article. Review.

7

2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.

Specht L. Specht L. Semin Radiat Oncol. 2007 Jul;17(3):190-7. doi: 10.1016/j.semradonc.2007.02.005. Semin Radiat Oncol. 2007. PMID: 17591566 Review.

8

TAC y PET/TC con 18-FDG para evaluar la respuesta al tratamiento en linfoma de Hodgkin y no Hodgkin.

Vargas-Partida T, Hernández-Cruz M, Ruiz-Eng R, Montiel-Jarquín ÁJ, Vázquez-Cruz E, López-Colombo A. Vargas-Partida T, et al. Gac Med Mex. 2019;155(4):386-390. doi: 10.24875/GMM.19005227. Gac Med Mex. 2019. PMID: 31486785 Free article.

9

PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma.

Kobe C, Dietlein M, Hellwig D. Kobe C, et al. Semin Nucl Med. 2018 Jan;48(1):28-36. doi: 10.1053/j.semnuclmed.2017.09.003. Epub 2017 Sep 19. Semin Nucl Med. 2018. PMID: 29195615 Review.

10

Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.

Sadik M, Lind E, Polymeri E, Enqvist O, Ulén J, Trägårdh E. Sadik M, et al. Clin Physiol Funct Imaging. 2019 Jan;39(1):78-84. doi: 10.1111/cpf.12546. Epub 2018 Oct 3. Clin Physiol Funct Imaging. 2019. PMID: 30284376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed